Aratana Therapeutics Inc. is a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats. The company aims to deliver best-in-class therapeutics, provide comprehensive service to veterinarians, and serve as a collaborator of choice for human and animal health companies. Aratana Therapeutics Inc.'s FDA-approved products include a prostaglandin receptor antagonist for osteoarthritis pain and inflammation in dogs, a ghrelin receptor agonist to stimulate appetite, and a long-acting local anesthetic for post-operative pain relief. The company was founded in 2010 and is based in Leawood, Kansas, USA.
Aratana Therapeutics Inc. believes its therapeutics are highly differentiated, addressing recognizable needs in compelling markets with superior therapeutic profiles compared to the standard of care. The company's mission is to successfully develop and deliver best-in-class therapeutics, providing comprehensive service to veterinarians and collaborating with other health companies. With a team of 15 employees, Aratana Therapeutics Inc. continues to innovate in the pet therapeutics space.
The company's focus on innovation and differentiation in pet therapeutics makes it a key player in the industry. Aratana Therapeutics Inc.'s commitment to improving the health and well-being of pets through advanced therapeutics positions it as a leader in the pet healthcare market.
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
| Ownership Public Company |
| Stock PETX (Nasdaq) |
B2B professionals should contact Aratana Therapeutics Inc. for innovative pet therapeutics solutions, potential partnerships, and vendor opportunities in the pet healthcare market. The company's commitment to delivering best-in-class therapeutics makes it an attractive partner for those looking to enhance pet health and well-being.
Sales teams selling pet healthcare products, recruiters seeking roles in pharmaceutical research, and partners offering veterinary services should reach out to Aratana Therapeutics Inc.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with Aratana Therapeutics Inc.